Cutstak

Cutstak is an injectable blend presentation based on Testosterone Propionate, Trenbolone Acetate, and Drostanolone Propionate, as identified on the product label. The label describes a combined composition of 100 mg Testosterone Propionate, 50 mg Trenbolone Acetate, and 50 mg Drostanolone Propionate in a 200 mg / 10 ml presentation. These compounds are commonly referenced in technical compound references for androgen receptor activity, anabolic-androgenic profile, and blend classification.

This product is organized within the XPharma catalog for product identification, label review, commercial reference, and documentation requests.

This page does not provide usage guidance, medical advice, or performance claims. Composition, regulatory status, market availability, and supporting documentation should be confirmed through official XPharma channels.